The association of vitamine D deficiency and skeletal muscle dysfunction in COPD Hyun Jung Jin (Daegu, Republic of Korea), Hyun Jung Jin, Kwan Ho Lee, Jin Hong Chung, Kyeong-Cheol Shin, Dong Won Lee
| |
Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index Lucas Boeck (Basel, Switzerland), Lucas Boeck, Kostantinos Kostikas, Francesco Blasi, Wim Boersma, Branislava Milenkovic, Alicia Lacoma, Renaud Louis, Joachim Aerts, Tobias Welte, Antoni Torres, Gernot Rohde, Janko Rakic, Andreas Scherr, Michael Koller, Michael Tamm, Daiana Stolz
| |
Survivin in patients with chronic obstructive pulmonary disease Apostolos Bossios (Gothenburg, Sweden), Apostolos Bossios, Linda Ekerljung, Minna Turkkila, Carina Malmhäll, Malin Erlandsson, Sofia Töyra Silfverswärd, Bo Lundbäck, Maria Bokarewa
| |
Antinuclear autoantibodies (ANA) and C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD) Abdel Monem Elshabrawi (Suez, Egypt), Hussien Abo-Alyazid, Ezzat Rezk, Abd Elmonem Elshabrawi, Kamel Hasan, Mokhles Ibrahim, Mahmoud Sayed, Ibrahim Abo- Elfetouh
| |
Validation of a four point sputum colour chart in chronic obstructive pulmonary disease Mark McKane (Dundee, United Kingdom), Mark McKane, Megan Crichton, Alison Dicker, James Chalmers
| |
The potential value of FRAX index and bone turnover markers to identify osteoporosis in COPD patients Pilar Rivera Ortega (Barcelona, Spain), Pilar Rivera-Ortega, Jessica González-Gutiérrez, Patricia Restituto, Nerea Varo, Amparo Calleja, Macarena Rodríguez, Ana B. Alcaide, Arantza Campo, Javier J. Zulueta, Juan P. De Torres
| |
Blood eosinophils as a biomarker in alpha 1 anti trypsin deficiency Safia Zaffarullah (London, United Kingdom), Safia Zaffarullah, Alice M. Turner, Robert Stockley, Diane Griffiths, Ross Edgar
| |
Telehome monitoring (THM) in COPD: A new model of evaluating nocturnal oxygen desaturation Maurizio Moretti (Modena, Italy), Anna Porcu, Sara Balestracci, Francesco Costa, Maurizio Morertti
| |
Nocturnal desaturation in COPD patients; is OSA screening the answer? Akanksha Das (Navi Mumbai, India), Akanksha Das, T.K. Jayalakshmi, Aparna Iyer, Bhumika Madhav, Pragati Agarwal, Amit Nagpal
| |
Lung clearance index is increased in patients with COPD Sebastian Fähndrich (Homburg/Saar, Germany), Sebastian Faehndrich, Martina Seibert, Philipp M. Lepper, Heinrike Wilkens, Stefan Wagenpfeil, Robert Bals
| |
A network-based approach to defining phenotypes in COPD Lucretia Udrescu (Timisoara, Romania), Lucretia Udrescu, Mihai Udrescu, Alexandru Topîrceanu, Stefan Mihaicuta
| |
A liquid chromatography MS/MS metabolomics study of COPD patients Barbora Novotná (Hradec Kralove, Czech Republic), Barbora Novotna, Mohammed Abdel-Hamid, Vladimir Koblizek, Jiri Jarkovsky, Karel Hejduk, Vit Rehacek, Josef Bis, Frantisek Salajka
| |
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease Panagiota Tzani (Parma, Italy), Roberta Pisi, Marina Aiello, Andrea Zanini, Panagiota Tzani, Davide Paleari, Emilio Marangio, Antonio Spanevello, Gabriele Nicolini, Alfredo Chetta
| |
Impulse oscillation respiratory reactance and airway reversibility in chronic obstructive pulmonary disease Yasushi Yamamoto (Asahikawa, Japan), Yasushi Yamamoto, Shinobu Osanai, Yoshihiro Kazebayashi, Noriko Hirai, Shunsuke Okumura, Takaaki Sasaki, Yoshinobu Ohsaki
| |
The influence of statin supplementation on inflammatory markers in patients with chronic obstructive pulmonary disease Mradul Daga (New Delhi, India), Mradul Daga, Ankit Chhoda, Naushad Ahmad Khan, Govind Mawari
| |
Significance of neutrophil to lymphocyte ratio in patients of chronic obstructive pulmonary diseases: A prospective study at tertiary care centre in India Deepak Shah (Varanasi, India), D.K. Shah, J.K. Mishra
| |
Asthma control in preschool wheezing children Paula Pinto (Lisbon, Portugal), Paula Leiria-Pinto, Pedro Martins, Elena Finelli, Joana Belo, João Marques, Isabel Peralta, Miguel Paiva, Sara Prates, Nuno Neuparth
| |
Stable state fibrinogen is additive to MR-proADM as a predictor of mortality in COPD patients Maaike Telgen (Enschede, Netherlands), Maaike Zuur-Telgen, Paul Van der Valk, Bram Zuur, Job Van der Palen, Huib Kerstjens, Marjolein Brusse-Keizer
| |